GNFT
Price
$3.94
Change
+$0.06 (+1.55%)
Updated
Sep 5 closing price
Capitalization
200.61M
14 days until earnings call
ORMP
Price
$2.23
Change
+$0.01 (+0.45%)
Updated
Sep 5 closing price
Capitalization
91.44M
67 days until earnings call
Interact to see
Advertisement

GNFT vs ORMP

Header iconGNFT vs ORMP Comparison
Open Charts GNFT vs ORMPBanner chart's image
Genfit SA
Price$3.94
Change+$0.06 (+1.55%)
Volume$6.2K
Capitalization200.61M
Oramed Pharmaceuticals
Price$2.23
Change+$0.01 (+0.45%)
Volume$58.88K
Capitalization91.44M
GNFT vs ORMP Comparison Chart in %
Loading...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNFT vs. ORMP commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNFT is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (GNFT: $3.94 vs. ORMP: $2.23)
Brand notoriety: GNFT and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNFT: 197% vs. ORMP: 84%
Market capitalization -- GNFT: $200.61M vs. ORMP: $91.44M
GNFT [@Biotechnology] is valued at $200.61M. ORMP’s [@Biotechnology] market capitalization is $91.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNFT’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • GNFT’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than GNFT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNFT’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 5 bullish TA indicator(s).

  • GNFT’s TA Score: 5 bullish, 5 bearish.
  • ORMP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than GNFT.

Price Growth

GNFT (@Biotechnology) experienced а -1.50% price change this week, while ORMP (@Biotechnology) price change was +1.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

GNFT is expected to report earnings on Sep 22, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNFT($201M) has a higher market cap than ORMP($91.4M). GNFT has higher P/E ratio than ORMP: GNFT (112.64) vs ORMP (20.91). GNFT YTD gains are higher at: 6.057 vs. ORMP (-7.851).
GNFTORMPGNFT / ORMP
Capitalization201M91.4M220%
EBITDAN/A-22.07M-
Gain YTD6.057-7.851-77%
P/E Ratio112.6420.91539%
RevenueN/A2M-
Total CashN/A97.9M-
Total DebtN/A912K-
FUNDAMENTALS RATINGS
GNFT vs ORMP: Fundamental Ratings
GNFT
ORMP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
5658
P/E GROWTH RATING
1..100
247
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (53) in the Pharmaceuticals Other industry is in the same range as GNFT (82) in the Biotechnology industry. This means that ORMP’s stock grew similarly to GNFT’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as GNFT (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to GNFT’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as GNFT (97) in the Biotechnology industry. This means that ORMP’s stock grew similarly to GNFT’s over the last 12 months.

GNFT's Price Growth Rating (56) in the Biotechnology industry is in the same range as ORMP (58) in the Pharmaceuticals Other industry. This means that GNFT’s stock grew similarly to ORMP’s over the last 12 months.

GNFT's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for ORMP (47) in the Pharmaceuticals Other industry. This means that GNFT’s stock grew somewhat faster than ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNFTORMP
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 25 days ago
70%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IOFNF0.350.01
+1.69%
Iofina Plc
EJPRY12.670.12
+0.96%
East Japan Railway Co.
JUMSY35.15N/A
N/A
Jumbo SA
SPSTY7.52N/A
N/A
Singapore Post, Ltd.
REVFF0.16N/A
N/A
REV Explorations Corp.

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.45%
BTAI - ORMP
44%
Loosely correlated
+6.16%
INO - ORMP
44%
Loosely correlated
+1.45%
MBIO - ORMP
44%
Loosely correlated
-2.72%
ZNTL - ORMP
43%
Loosely correlated
-1.13%
RVMD - ORMP
42%
Loosely correlated
+3.98%
More